drugset / Trial / NCT06535945
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).
Timeline
- Start
- 2025-03-26
- Primary completion
- 2028-04-26
- Completion
- 2028-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | — | — |